Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole
Bioorganic & Medicinal Chemistry Letters · 2023
DOI: 10.1016/j.bmcl.2023.129484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2023. Verfasst von Takashi Tsuji und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima 770-8505, Japan. Hauptthemen laut MEDLINE: Prodrugs, Nitroimidazoles, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Hypoxia in cancer is important in the development of cancer-selective medicines. Here, a novel hypoxia-responsible dual-prodrug is described. We designed and synthesized 2-nitroimidazole derivatives which spontaneously release both a PYG inhibitor and gemcitabine under hypoxic conditions. One such derivative, a prodrug 9 was found to be stable against chemical and enzymatic hydrolysis, and upon chemical reduction of the nitro group on imidazole, successfully releases both drugs. In an in vitro proliferation assay using human pancreatic cells, compound 9 exhibited significant anti-proliferative effects in hypoxia but fewer effects in normoxia. Consequently, prodrug 9 should be useful for cancer treatment due to its improved cancer selectivity and potential to overcome drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima 770-8505, Japan.
- Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima 770-8505, Japan. Electronic address: aotaka@tokushima-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tsuji, T., Tsunematsu, H., Imanishi, M., Denda, M., Tsuchiya, K., & Otaka, A. (2023). Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129484
Vancouver
Tsuji T, Tsunematsu H, Imanishi M, Denda M, Tsuchiya K, Otaka A. Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole. Bioorganic & Medicinal Chemistry Letters. 2023. doi:10.1016/j.bmcl.2023.129484
BibTeX
@article{Tsuji2023,
author = {Tsuji, Takashi and Tsunematsu, Honoka and Imanishi, Masaki and Denda, Masaya and Tsuchiya, Koichiro and Otaka, Akira},
title = {Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2023},
doi = {10.1016/j.bmcl.2023.129484}
}
EUVIMED